• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国人乳头瘤病毒检测在宫颈癌筛查中的应用。

Utility of Human Papillomavirus Testing for Cervical Cancer Screening in Korea.

机构信息

Department of Pathology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon 51353, Korea.

Department of Pathology, Dong-A University College of Medicine, Busan 49201, Korea.

出版信息

Int J Environ Res Public Health. 2020 Mar 6;17(5):1726. doi: 10.3390/ijerph17051726.

DOI:10.3390/ijerph17051726
PMID:32155755
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7084278/
Abstract

(1) Background: Cervical cancer is one of the most common cancers in Korean women. This study was performed to discover the utility of HPV (Human Papillomavirus) testing in screening of cervical lesions and to provide the prevalence of HPV and the genotype distribution in a single center of Korea. (2) Methods: A total of 15,141 women who underwent both HPV testing and cervical cytology were enrolled in this retrospective medical record review study. (3) Results: HPV testing showed higher sensitivity than cytology for the detection of histological high-grade squamous lesions. Furthermore, the sensitivity and specificity of HPV testing varied depending on the method used. The BD Onclarity™ HPV assay had higher sensitivity (90%) than the MyHPV CHIP™ kit (all types of HPV: 82%; high-risk HPV: 76%) for high-grade squamous lesions. A combination of MyHPV CHIP™ and cytology detected 90.9% (30/33) of histological high-grade squamous lesions. A combination of BD Onclarity™ HPV assay and cytology detected 96.55% (84/87) of histological high-grade squamous lesions. In addition, HPV prevalence and genotype distribution were different depending on the HPV testing method used. (4) Conclusion: HPV testing showed higher sensitivity than cytology, but the sensitivity and specificity of HPV testing had variation depending on the method used.

摘要

(1)背景:宫颈癌是韩国女性最常见的癌症之一。本研究旨在探讨 HPV(人乳头瘤病毒)检测在宫颈病变筛查中的应用价值,并提供韩国单一中心 HPV 的流行率及基因型分布情况。(2)方法:本回顾性病历研究共纳入 15141 名同时接受 HPV 检测和宫颈细胞学检查的女性。(3)结果:HPV 检测在检测组织学高级别鳞状病变方面的敏感性高于细胞学检查。此外,HPV 检测的敏感性和特异性因检测方法的不同而有所差异。BD Onclarity™ HPV 检测(所有 HPV 类型:82%;高危型 HPV:76%)对高级别鳞状病变的敏感性高于 MyHPV CHIP™ 试剂盒(90%)。MyHPV CHIP™ 试剂盒联合细胞学检查检测出 30/33 例组织学高级别鳞状病变。BD Onclarity™ HPV 检测联合细胞学检查检测出 84/87 例组织学高级别鳞状病变。此外,HPV 的流行率和基因型分布因 HPV 检测方法的不同而有所差异。(4)结论:HPV 检测的敏感性高于细胞学检查,但 HPV 检测的敏感性和特异性因检测方法的不同而有所差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df35/7084278/1c248976b982/ijerph-17-01726-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df35/7084278/1746b4963130/ijerph-17-01726-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df35/7084278/1c248976b982/ijerph-17-01726-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df35/7084278/1746b4963130/ijerph-17-01726-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df35/7084278/1c248976b982/ijerph-17-01726-g002.jpg

相似文献

1
Utility of Human Papillomavirus Testing for Cervical Cancer Screening in Korea.韩国人乳头瘤病毒检测在宫颈癌筛查中的应用。
Int J Environ Res Public Health. 2020 Mar 6;17(5):1726. doi: 10.3390/ijerph17051726.
2
Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.2014-2016 年韩国筛查人群中人类乳头瘤病毒基因型和宫颈癌前病变的流行情况。
J Gynecol Oncol. 2018 Jan;29(1):e14. doi: 10.3802/jgo.2018.29.e14.
3
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.25 岁及以上女性宫颈癌筛查中致癌型人乳头瘤病毒(HPV)检测及 HPV16 或 HPV18 基因分型的性能:ATHENA 研究的一项亚组分析。
Lancet Oncol. 2011 Sep;12(9):880-90. doi: 10.1016/S1470-2045(11)70188-7. Epub 2011 Aug 22.
4
Human papillomavirus test with cytology triage in organized screening for cervical cancer.在宫颈癌组织筛查中采用人乳头瘤病毒检测及细胞学分流
Acta Obstet Gynecol Scand. 2016 Nov;95(11):1220-1227. doi: 10.1111/aogs.13013.
5
The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.英格兰原发性人乳头瘤病毒子宫颈筛查的临床效果和成本效益:通过三轮筛查对 ARTISTIC 随机试验队列进行的扩展随访。
Health Technol Assess. 2014 Apr;18(23):1-196. doi: 10.3310/hta18230.
6
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.人乳头瘤病毒检测在高级别宫颈上皮内瘤变和宫颈癌筛查中的应用:POBASCAM 随机对照研究的最终结果。
Lancet Oncol. 2012 Jan;13(1):78-88. doi: 10.1016/S1470-2045(11)70296-0. Epub 2011 Dec 14.
7
Detection Rate of High-Grade Cervical Neoplasia and Cost-Effectiveness of High-Risk Human Papillomavirus Genotyping with Reflex Liquid-based Cytology in Cervical Cancer Screening.宫颈癌筛查中液基细胞学分流高危型人乳头瘤病毒基因检测用于高级别宫颈病变的检出率及成本效益分析。
Ann Acad Med Singap. 2017 Jul;46(7):267-273.
8
Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.人乳头瘤病毒基因分型与细胞学分流比较,COMPACT 研究:14642 例女性的设计、方法和基线结果。
Cancer Sci. 2018 Jun;109(6):2003-2012. doi: 10.1111/cas.13608. Epub 2018 May 31.
9
Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.在随机环境中对原发性人乳头瘤病毒筛查与传统细胞学进行特定年龄评估。
J Natl Cancer Inst. 2009 Dec 2;101(23):1612-23. doi: 10.1093/jnci/djp367. Epub 2009 Nov 9.
10
Reflex Human Papillomavirus Test Results as an Option for the Management of Korean Women With Atypical Squamous Cells Cannot Exclude High-Grade Squamous Intraepithelial Lesion.反射性人乳头瘤病毒检测结果作为韩国非典型鳞状细胞女性管理的一种选择不能排除高级别鳞状上皮内病变。
Oncologist. 2015 Jun;20(6):635-9. doi: 10.1634/theoncologist.2014-0459. Epub 2015 May 11.

引用本文的文献

1
Abnormal Pap smear among pregnant women - Feasibility of opportunistic cervical screening.孕妇宫颈涂片异常——机会性宫颈筛查的可行性
Eur J Obstet Gynecol Reprod Biol X. 2023 Jul 20;19:100218. doi: 10.1016/j.eurox.2023.100218. eCollection 2023 Sep.
2
Evaluation of the characteristics of multiple human papillomavirus (HPV) infections identified using the BD Onclarity HPV assay and comparison with those of single HPV infection.使用BD Onclarity HPV检测法鉴定的多重人乳头瘤病毒(HPV)感染特征评估及其与单一HPV感染特征的比较。
J Pathol Transl Med. 2022 Sep;56(5):289-293. doi: 10.4132/jptm.2022.08.02. Epub 2022 Sep 13.
3

本文引用的文献

1
Comparison of papanicolaou smear and human papillomavirus (HPV) test as cervical screening tools: can we rely on HPV test alone as a screening method? An 11-year retrospective experience at a single institution.巴氏涂片检查与人乳头瘤病毒(HPV)检测作为宫颈癌筛查工具的比较:我们能否仅依靠HPV检测作为一种筛查方法?来自单一机构的11年回顾性经验。
J Pathol Transl Med. 2020 Jan;54(1):112-118. doi: 10.4132/jptm.2019.11.29. Epub 2020 Jan 15.
2
High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology.高危型人乳头瘤病毒检测作为宫颈癌的初筛:韩国妇产科医师学会和韩国妇科肿瘤学会的立场声明。
J Gynecol Oncol. 2020 Jan;31(1):e31. doi: 10.3802/jgo.2020.31.e31. Epub 2019 Nov 8.
3
Comparison of Seegene Anyplex II HPV28 assay with BD Onclarity HPV assay for human papillomavirus genotyping.
与 BD Onclarity HPV 检测试剂盒相比,Seegene Anyplex II HPV28 检测试剂盒在人乳头瘤病毒基因分型方面的比较。
PLoS One. 2022 Jul 8;17(7):e0267836. doi: 10.1371/journal.pone.0267836. eCollection 2022.
4
Functional Gene Clusters in Global Pathogenesis of Clear Cell Carcinoma of the Ovary Discovered by Integrated Analysis of Transcriptomes.通过转录组综合分析发现的卵巢透明细胞癌全球发病机制中的功能基因簇
Int J Environ Res Public Health. 2020 Jun 2;17(11):3951. doi: 10.3390/ijerph17113951.
Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine sampling.三种不同宫颈癌筛查方式的满意度评估:临床医生采集的巴氏涂片检测与自我采样 HPV 检测和尿液采样 HPV 检测的比较。
J Gynecol Oncol. 2019 Sep;30(5):e76. doi: 10.3802/jgo.2019.30.e76.
4
Prediction of Cancer Incidence and Mortality in Korea, 2019.2019 年韩国癌症发病率和死亡率预测。
Cancer Res Treat. 2019 Apr;51(2):431-437. doi: 10.4143/crt.2019.139. Epub 2019 Mar 18.
5
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014.韩国癌症统计数据:2014年的发病率、死亡率、生存率及患病率
Cancer Res Treat. 2017 Apr;49(2):292-305. doi: 10.4143/crt.2017.118. Epub 2017 Mar 9.
6
Population-based study for human papillomavirus (HPV) infection in young women in Japan: A multicenter study by the Japanese human papillomavirus disease education research survey group (J-HERS).日本年轻女性人乳头瘤病毒(HPV)感染的基于人群的研究:日本人乳头瘤病毒疾病教育研究调查小组(J-HERS)的一项多中心研究。
J Med Virol. 2016 Feb;88(2):324-35. doi: 10.1002/jmv.24323.
7
Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China.中国37个城市人乳头瘤病毒感染的全国患病率及病毒基因型分布
BMC Infect Dis. 2015 Jul 4;15:257. doi: 10.1186/s12879-015-0998-5.
8
Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.原发性高危型人乳头瘤病毒检测用于宫颈癌筛查:临时临床指南
Obstet Gynecol. 2015 Feb;125(2):330-337. doi: 10.1097/AOG.0000000000000669.
9
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.HPV 检测在宫颈癌筛查中的效果:四项欧洲随机对照试验的随访研究。
Lancet. 2014 Feb 8;383(9916):524-32. doi: 10.1016/S0140-6736(13)62218-7. Epub 2013 Nov 3.
10
Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection.关于人乳头瘤病毒感染的流行病学、发病机制及预防的当前知识综述。
Eur J Cancer Prev. 2014 May;23(3):206-24. doi: 10.1097/CEJ.0b013e328364f273.